CN111228563A - Preparation method of silk fibroin and tannic acid composite medical adhesive - Google Patents

Preparation method of silk fibroin and tannic acid composite medical adhesive Download PDF

Info

Publication number
CN111228563A
CN111228563A CN202010053074.7A CN202010053074A CN111228563A CN 111228563 A CN111228563 A CN 111228563A CN 202010053074 A CN202010053074 A CN 202010053074A CN 111228563 A CN111228563 A CN 111228563A
Authority
CN
China
Prior art keywords
silk fibroin
freeze
tannic acid
adhesive
medical adhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010053074.7A
Other languages
Chinese (zh)
Inventor
曹晓东
高夕杰
董华
李庆涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China University of Technology SCUT
Original Assignee
South China University of Technology SCUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China University of Technology SCUT filed Critical South China University of Technology SCUT
Priority to CN202010053074.7A priority Critical patent/CN111228563A/en
Publication of CN111228563A publication Critical patent/CN111228563A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0073Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0015Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Composite Materials (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention discloses a preparation method of a silk fibroin and tannic acid composite medical adhesive, which comprises the following steps of taking silkworm silk fibroin and tannic acid as main raw materials, combining strong hydrogen bonds of the silk fibroin and the tannic acid to enable the silk fibroin to be rapidly separated out from a solution, thus obtaining the viscous silk fibroin and tannic acid composite adhesive, freeze-drying the prepared composite adhesive, grinding the composite adhesive into freeze-dried powder, paving the freeze-dried powder at a wound when in use, and forming adhesive to adhere to the wound and block the wound to realize wound sealing as soon as the freeze-dried powder meets water. The method for preparing the medical adhesive is simple and easy to implement, and the freeze-dried powder is convenient to store for a long time and is beneficial to sterilization before use.

Description

Preparation method of silk fibroin and tannic acid composite medical adhesive
Technical Field
The invention relates to the technical field of medical materials, in particular to a preparation method of a silk fibroin and tannic acid composite medical adhesive.
Background
The ideal medical adhesive is safe, non-toxic, non-irritating, non-teratogenic, high in adhesive strength, good in biocompatibility and antibacterial property, capable of being used under the condition of existence of blood and tissue fluid, free of degradation product dissolution influencing healing, free of cytotoxicity, low in heat generated by curing and the like.
Disclosure of Invention
The invention aims to overcome the defects of the prior art, provides a preparation method of a silk fibroin and tannin composite medical adhesive, and particularly provides a preparation method of a medical adhesive used in a freeze-dried powder form, wherein the freeze-dried powder form is not only beneficial to long-time storage, but also convenient for sterilization before use, which is a very important link before the medical adhesive is used. When in use, the freeze-dried powder is spread on a wound to absorb water (spray a small amount of water) and coagulate so as to realize wound sealing, and since silk fibroin and tannic acid are natural biological materials, the silk fibroin and tannic acid composite has good biocompatibility, no toxic or side effect and can be degraded and metabolized in tissues.
In order to achieve the purpose, the technical scheme provided by the invention is as follows: the preparation method of the silk fibroin and tannin composite medical adhesive comprises the following steps:
1) adding a lithium bromide solution into the degummed silk, heating for dissolving, and dialyzing to obtain a silk fibroin solution;
2) adding a tannic acid solution into the silk fibroin solution until the mixed solution is light yellow, stirring to uniformly mix, standing until the solution becomes clear and transparent from turbidity, and removing the supernatant to obtain a silk fibroin and tannic acid compound;
3) the silk fibroin and tannin composite is freeze-dried and ground to obtain composite freeze-dried powder, namely the silk fibroin and tannin composite medical adhesive, namely the medical adhesive is in a freeze-dried powder use form, and the freeze-dried powder is sprayed with water to be coagulated when the medical adhesive is used.
In the step 1), the degummed silk is silk fibroin obtained by degummed silkworm silk.
In the step 2), the concentration of the silk fibroin solution is 1-7 w/w%.
In the step 2), the concentration of the tannic acid solution is between 5 and 60 w/v%.
Compared with the prior art, the invention has the following advantages and beneficial effects:
1. the raw materials of the composite freeze-dried powder prepared by the invention are only silk fibroin and tannic acid, and the composite freeze-dried powder is simple in raw material, wide in source and low in cost.
2. The silk fibroin and the tannin are respectively natural animal protein and natural plant polyphenol, and have the advantages of good biocompatibility and biodegradability in vivo.
3. The reaction process only needs simple mixing to form the compound through physical crosslinking reaction without complicated chemical synthesis process.
4. The adhesive is stored in a freeze-dried powder form, so that the stability of the material is improved, and sterilization before use is more convenient.
5. The prepared composite freeze-dried powder can be recovered into the adhesive to seal the wound when meeting water, and the operation is simple and easy to implement and the reaction is mild.
6. The silk fibroin has the anti-swelling property, and can avoid the excessive expansion of the adhesive in the body to cause the tissue extrusion.
7. The tannic acid has an antibacterial function and can reduce the risk of adhesive bacterial contamination.
Drawings
FIG. 1 is a photograph of an OHP film adhesion tensile test.
Fig. 2 is a photograph of a tissue adhesion tensile test.
Fig. 3 is a photograph of the adhesion of glue to the heart.
Detailed Description
The invention is further illustrated below with reference to a number of specific examples.
Example 1
Adding lithium bromide solution into degummed silk (specifically silk fibroin obtained by degummed silkworm silk), heating for dissolving, dialyzing to obtain silk fibroin solution, mixing 1 w/w% silk fibroin solution with 5 w/v% tannic acid solution, stirring, standing for several hours, removing clear solution, freeze drying the precipitate, grinding into powder, wetting and condensing 10mg of lyophilized powder, placing between two OHP films, and making contact area between viscose and OHP be 10 × 5mm2The adhesive strength of the adhesive was tested in a 180 ° tensile test mode using a texture analyzer (as shown in fig. 1), with 3 replicates.
Example 2
Adding lithium bromide solution into degummed silk (specifically silk fibroin obtained by degummed silkworm silk), heating for dissolving, dialyzing to obtain silk fibroin solution, mixing 7 w/w% silk fibroin solution with 5 w/v% tannic acid solution, stirring, standing for several hours, removing clear solution, freeze drying the precipitate, grinding into powder, wetting and condensing 10mg of lyophilized powder, placing between two OHP films, and making contact area between viscose and OHP be 10 × 5mm2The adhesive strength of the adhesive was tested in a 180 ° tensile test mode using a texture analyzer (as shown in fig. 1), with 3 replicates.
Example 3
Adding lithium bromide solution into degummed silk (specifically silk fibroin obtained by degummed silkworm silk), heating for dissolving, dialyzing to obtain silk fibroin solution, mixing 3 w/w% silk fibroin solution with 30 w/v% tannic acid solution, stirring, standing for several hours, removing clear liquid, freeze drying the precipitate, grinding into powder, and collecting lyophilized powder 10mg of the solution is wetted and coagulated and then placed between two OHP films, and the contact area between the viscose and the OHP films is 10 multiplied by 5mm2The adhesive strength of the adhesive was tested in a 180 ° tensile test mode using a texture analyzer (as shown in fig. 1), with 3 replicates.
Example 4
Adding lithium bromide solution into degummed silk (specifically silk fibroin obtained by degummed silkworm silk), heating for dissolving, dialyzing to obtain silk fibroin solution, mixing 1 w/w% silk fibroin solution with 60 w/v% tannic acid solution, stirring, standing for several hours, discarding clear solution, freeze-drying the precipitate, grinding into powder, wetting and condensing 10mg of lyophilized powder, placing between two OHP films, and making contact area between viscose and OHP be 10 × 5mm2The adhesive strength of the adhesive was tested in a 180 ° tensile test mode using a texture analyzer (as shown in fig. 1), with 3 replicates.
Example 5
Adding lithium bromide solution into degummed silk (specifically silk fibroin obtained by degummed silkworm silk), heating for dissolving, dialyzing to obtain silk fibroin solution, mixing 7 w/w% silk fibroin solution with 60 w/v% tannic acid solution, stirring, standing for several hours, discarding clear solution, freeze-drying the precipitate, grinding into powder, wetting and condensing 10mg of lyophilized powder, placing between two OHP films, and making contact area between viscose and OHP be 10 × 5mm2The adhesive strength of the adhesive was tested in a 180 ° tensile test mode using a texture analyzer (as shown in fig. 1), with 3 replicates.
The specific detection results of the above examples 1 to 5 are shown in the following table 1:
TABLE 1 adhesion Strength values of adhesives in the examples
Figure BDA0002371891650000051
The following experiments are carried out on the prepared silk fibroin and tannin composite medical adhesive:
example 6 (Water adhesion resistance of composite medical adhesive of Silk fibroin and tannin)
(1) Preparation of the experiment: the lyophilized powder obtained in example 3 was wetted with a small amount of water to obtain a corresponding adhesive and placed between two OHP films having a width of 10mm and a contact area of 10X 5mm2After full contact, the mixture is respectively placed in deionized water for 5h, 3h, 1h, 30min and 10 min.
(2) Adhesion testing: the adhesive strength of each set of samples was tested using a 180 ° tensile test mode of a texture analyzer at a tensile speed of 50mm/min for each set of three replicates. The test results are shown in table 2 below:
TABLE 2 adhesion properties after soaking for various periods of time
Figure BDA0002371891650000052
As can be seen from the results in the table, the adhesive has good adhesive performance, and the adhesive strength is not only not influenced by the soaking time, but also enhanced due to the prolonged time.
Example 7 (adhesive Property of composite medical adhesive of Silk fibroin and tannin to tissue)
(1) Preparation of the experiment: adding a small amount of water into the freeze-dried powder obtained in example 3 to wet the freeze-dried powder to obtain a corresponding adhesive, placing the adhesive at one end of two pieces of OHP films with the width of 10mm, and connecting the other side of the adhesive with the thickness of 30X 20mm2The rabbit tissue was contacted at both ends, placed at room temperature and two slides placed on top, and allowed to fully contact the OHP membrane under a certain force (as shown in figure 2).
(2) Adhesion testing: and testing the adhesive strength of the adhesive by using a 180-degree tensile test mode of a texture analyzer, wherein the tensile speed is 50mm/min, and three samples are parallel. The resulting adhesive strength was the maximum value of the tensile force measured divided by the contact area of the adhesive with the OHP film (0.01X 0.005 m)2) The adhesion values to rabbit skin, rabbit liver and rabbit heart were: 10.9 +/-3.3 kPa, 8.5 +/-3.6 kPa and 8.7 +/-3.1 kPa.
Example 8 (Heart burst pressure test)
(1) Sample preparation: the rabbit heart was sampled, the blood stasis in the heart was squeezed out, a hole with a diameter of 2mm was drilled in the right ventricle, 60mg of the lyophilized powder of example 3 was coated on and around the hole in a circular shape with a diameter of 10mm, and the lyophilized powder was then wetted with physiological saline to adhere to the heart (as shown in fig. 3).
And (3) testing the blasting pressure: burst pressure testing was performed using a home-made device with a 50ml syringe and a digital pressure display. The syringe is filled with normal saline, and is injected into the heart at the speed of 2ml/min, and the joint with the heart and the rest part of the right ventricle of the heart, which is communicated with the outside, are sealed by glue. The number of replicates was 3. The obtained burst pressure value is 31.8 + -7.4 mmHg, and when a hard OHP film is added on the surface of the adhesive as a support, the burst pressure value can be increased to 46.8 + -17.1 mmHg.
The above-mentioned embodiments are merely preferred embodiments of the present invention, and the scope of the present invention is not limited thereto, so that the changes in the shape and principle of the present invention should be covered within the protection scope of the present invention.

Claims (4)

1. The preparation method of the silk fibroin and tannin composite medical adhesive is characterized by comprising the following steps:
1) adding a lithium bromide solution into the degummed silk, heating for dissolving, and dialyzing to obtain a silk fibroin solution;
2) adding a tannic acid solution into the silk fibroin solution until the mixed solution is light yellow, stirring to uniformly mix, standing until the solution becomes clear and transparent from turbidity, and removing the supernatant to obtain a silk fibroin and tannic acid compound;
3) the silk fibroin and tannin composite is freeze-dried and ground to obtain composite freeze-dried powder, namely the silk fibroin and tannin composite medical adhesive, namely the medical adhesive is in a freeze-dried powder use form, and the freeze-dried powder is sprayed with water to be coagulated when the medical adhesive is used.
2. The preparation method of the silk fibroin and tannin composite medical adhesive according to claim 1, which is characterized by comprising the following steps: in the step 1), the degummed silk is silk fibroin obtained by degummed silkworm silk.
3. The preparation method of the silk fibroin and tannin composite medical adhesive according to claim 1, which is characterized by comprising the following steps: in the step 2), the concentration of the silk fibroin solution is 1-7 w/w%.
4. The preparation method of the silk fibroin and tannin composite medical adhesive according to claim 1, which is characterized by comprising the following steps: in the step 2), the concentration of the tannic acid solution is between 5 and 60 w/v%.
CN202010053074.7A 2020-01-17 2020-01-17 Preparation method of silk fibroin and tannic acid composite medical adhesive Pending CN111228563A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010053074.7A CN111228563A (en) 2020-01-17 2020-01-17 Preparation method of silk fibroin and tannic acid composite medical adhesive

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010053074.7A CN111228563A (en) 2020-01-17 2020-01-17 Preparation method of silk fibroin and tannic acid composite medical adhesive

Publications (1)

Publication Number Publication Date
CN111228563A true CN111228563A (en) 2020-06-05

Family

ID=70861761

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010053074.7A Pending CN111228563A (en) 2020-01-17 2020-01-17 Preparation method of silk fibroin and tannic acid composite medical adhesive

Country Status (1)

Country Link
CN (1) CN111228563A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112587715A (en) * 2021-01-08 2021-04-02 成都煌泓亢环保科技有限公司 Preparation method of high-adhesion medical composite adhesive
CN113279253A (en) * 2021-04-02 2021-08-20 百事基材料(青岛)股份有限公司 Silk large biological fiber containing coffee active component and preparation method thereof
CN113398323A (en) * 2021-06-30 2021-09-17 华中科技大学同济医学院附属协和医院 Preparation method and application of sericin adhesive
CN114808454A (en) * 2022-05-05 2022-07-29 苏州大学 Amorphous colloid array structure yarn-dyed fabric and preparation method thereof
CN115779138A (en) * 2022-11-24 2023-03-14 山东宝森新材料科技有限公司 Silk fibroin hemostatic powder and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108159484A (en) * 2018-03-22 2018-06-15 湖南工业大学 A kind of preparation method for the repair hydrogel that stops blooding
CN108744023A (en) * 2018-06-15 2018-11-06 福州大学 A kind of fibroin albumen medical bio adhesive and preparation method thereof
US20180361015A1 (en) * 2015-11-30 2018-12-20 Trustees Of Tufts College Silk-Based Adhesives
WO2019221559A1 (en) * 2018-05-18 2019-11-21 포항공과대학교 산학협력단 Microneedle adhesive patch based on hydrogel formulation
CN110483630A (en) * 2019-08-07 2019-11-22 苏州蔓尔生物科技有限公司 A kind of preparation method of modified fibroin protein freeze-dried powder

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180361015A1 (en) * 2015-11-30 2018-12-20 Trustees Of Tufts College Silk-Based Adhesives
CN108159484A (en) * 2018-03-22 2018-06-15 湖南工业大学 A kind of preparation method for the repair hydrogel that stops blooding
WO2019221559A1 (en) * 2018-05-18 2019-11-21 포항공과대학교 산학협력단 Microneedle adhesive patch based on hydrogel formulation
CN108744023A (en) * 2018-06-15 2018-11-06 福州大学 A kind of fibroin albumen medical bio adhesive and preparation method thereof
CN110483630A (en) * 2019-08-07 2019-11-22 苏州蔓尔生物科技有限公司 A kind of preparation method of modified fibroin protein freeze-dried powder

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周长忍: "《生物材料学》", 30 April 2004, 中国医药科技出版社 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112587715A (en) * 2021-01-08 2021-04-02 成都煌泓亢环保科技有限公司 Preparation method of high-adhesion medical composite adhesive
CN113279253A (en) * 2021-04-02 2021-08-20 百事基材料(青岛)股份有限公司 Silk large biological fiber containing coffee active component and preparation method thereof
CN113398323A (en) * 2021-06-30 2021-09-17 华中科技大学同济医学院附属协和医院 Preparation method and application of sericin adhesive
CN114808454A (en) * 2022-05-05 2022-07-29 苏州大学 Amorphous colloid array structure yarn-dyed fabric and preparation method thereof
CN115779138A (en) * 2022-11-24 2023-03-14 山东宝森新材料科技有限公司 Silk fibroin hemostatic powder and preparation method and application thereof
CN115779138B (en) * 2022-11-24 2024-05-24 山东宝森新材料科技有限公司 Silk fibroin hemostatic powder and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN111228563A (en) Preparation method of silk fibroin and tannic acid composite medical adhesive
CN105327388B (en) A kind of adhesive of medical and preparation method thereof
US8673354B2 (en) Adhesives and methods of applying the same
EP2143771B1 (en) Adhesive compound, in particular for use in surgical medicine
CN103463669A (en) Liquid wound dressing and preparation method thereof
CN101824160A (en) Preparation method of chitosan/polyvinyl alcohol/polylactic acid blended porous membrane
CN106913900B (en) Silk fibroin hemostatic material and preparation method thereof
EP0466383A1 (en) A collagen medical adhesive and its uses
CN113633817A (en) In-situ polymerization strongly-adhered antibacterial hemostatic hydrogel and preparation method and application thereof
CN105477674A (en) Hemostasis composite material based on chitosan and marine mussel mucin and preparation method of hemostasis composite material
CN113563681B (en) Degradable wet-state adhesive hydrogel material and preparation method and application thereof
CN113372585A (en) Preparation method and application of hydrogel with high-adhesion composite function
CN106866996A (en) A kind of fast preparation method of silk fibroin matter gel
WO2023198126A1 (en) Medical tissue adhesive used for sealing pancreas, preparation method therefor, and use thereof
CN112843325A (en) Medical hydrogel adhesive and preparation method and application thereof
CN109824917A (en) A kind of self-healing and the hydrogel of injectable and the preparation method and application thereof
CN112121065A (en) Medical styptic powder and application thereof
CN112143410B (en) Injectable biological adhesive and preparation method and application thereof
CN111053946B (en) Bi-component tissue adhesive based on polysaccharide and hyperbranched polypeptide and preparation method thereof
CN116785491A (en) Porous composite hemostatic sponge and preparation method thereof
CN109125795A (en) A kind of polysaccharide hemostatic composition and the preparation method and application thereof
CN114848668B (en) Composition with functions of promoting wound healing and rapidly stopping bleeding
WO2022217733A1 (en) Medical hydrogel and preparation method therefor and use thereof
CN114524952B (en) Preparation method of high-adhesion natural eggshell membrane chitosan hydrogel
CN110420345A (en) High water absorption antibacterial anti hemorrhagic sponge

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200605